Skip to main content
. 2018 Mar 23;15(5):7555–7562. doi: 10.3892/ol.2018.8340

Figure 1.

Figure 1.

GOLPH3 expression in NSCLC. (A) mRNA expression of GOLPH3 in NSCLC tissues and ANT from 60 patients. ***P<0.001. (B) Representative images from immunohistochemistry analysis of NSCLC tissues and ANT for the protein expression of GOLPH3 (magnification, ×100). (C) Representative images of tissues with low and high GOLPH3 expression (magnification, ×100). (D) High expression of GOLPH3 is significantly correlated with poor overall survival in patients with NSCLC. GOLPH3, Golgi phosphoprotein 3; NSCLC, non-small cell lung cancer; ANT, adjacent non-cancerous tissue.